Cập nhật pháp chế
20 thg 9, 2026•1 phút đọc
KPA and MFDS to Hold Parametric Release Training for Sterile Product Manufacturers on Sep 29
The Korea Pharmaceutical Bio Association and the Ministry of Food and Drug Safety will host a technical training on parametric release for final sterilized product manufacturers on September 29 in Cheongju.
Cập nhật pháp chế
17 thg 9, 2026•1 phút đọc
MFDS reports 7 GMP observations for Kyungbang Shinyak, all classified as "Other"
The Ministry of Food and Drug Safety disclosed that Kyungbang Shinyak received seven GMP observations in facility equipment and manufacturing, all categorized as "Other" with no major issues.
Cập nhật pháp chế
14 thg 9, 2026•1 phút đọc
Korea United Pharm’s Sejong Plant Retains GMP Certification after Ukrainian Inspection
Korea United Pharm announced that its Sejong‑1 plant passed a re‑inspection by Ukraine’s drug regulator, maintaining its GMP certification.
Cập nhật pháp chế
11 thg 9, 2026•1 phút đọc
MFDS Revises Pharmaceutical Pre‑GMP Evaluation Manual, Adds New‑Drug and Singapore GMP Provisions
South Korea's MFDS updates its pre‑GMP evaluation handbook after 5 years, introducing dedicated teams for new drugs and incorporating the Korea‑Singapore GMP mutual‑recognition agreement.
Cập nhật pháp chế
30 thg 8, 2026•1 phút đọc
경방신약, 기준서 미준수로 의약품 제조 1개월 정지
경방신약이 제조관리기준서 등 지시서 미준수로 식품의약품안전처로부터 7월 한 달간 두 품목 제조 정지 처분을 받았다.
8
Cập nhật pháp chế
25 thg 8, 2026•1 phút đọc
FDA Recalls Drug Over Adulterated API and Content Uniformity Failure
The FDA has recalled a product after discovering an adulterated active ingredient and insufficient manufacturing controls that caused content uniformity failures.
Cập nhật pháp chế
24 thg 8, 2026•1 phút đọc
FDA Identifies GMP Violations Affecting Sterility Assurance
An FDA inspection uncovered GMP violations that may compromise product sterility and quality, prompting a recall.
Cập nhật pháp chế
24 thg 8, 2026•1 phút đọc
PMDA Asia Office GMP Workshop Training 2026 Report Published
The Pharmaceuticals and Medical Devices Agency (PMDA) has posted the report for its 2026 Asia Office GMP Workshop Training.
Cập nhật pháp chế
23 thg 8, 2026•1 phút đọc
FDA Recalls Product Over Sterility Concerns Due to GMP Violations
The FDA has initiated a recall after an inspection revealed GMP violations that could compromise product sterility.
1
Cập nhật pháp chế
23 thg 8, 2026•1 phút đọc
Orbit Pharma Recalls Cyclizine Lactate Injection Batch Over GMP Deficiencies
Orbit Pharma Limited is recalling a batch of Cyclizine Lactate 50 mg/ml injection solution due to GMP deficiencies at the manufacturing site.
1